RT Journal Article
SR Electronic
T1 Dr. Kang, <em>et al</em>, reply
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.181446
DO 10.3899/jrheum.181446
A1 Amy Kang
A1 Marilina Antonelou
A1 Nikki L.  Wong
A1 Anisha Tanna
A1 Nishkantha Arulkumaran
A1 Frederick W.K.  Tam
A1 Charles D.  Pusey
YR 2019
UL http://www.jrheum.org/content/early/2019/06/24/jrheum.181446.abstract
AB We were surprised to read the letter by Berti and colleagues1, commenting on our recent article on the incidence of arterial and venous thrombosis in antineutrophil cytoplasmic antibody–associated vasculitis (AAV)2. They make the unjustified comment that “the incidence estimates for [arterial (ATE) and venous thrombosis events (VTE)] may be inflated” when we give clear and accurate incidence rates.